Total Payments
$4,961
2024 Payments
$177.60
Companies
11
Transactions
52
Payment Breakdown by Category
Other$3,715 (74.9%)
Food & Beverage$1,143 (23.0%)
Education$103.06 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $3,715 | 2 | 74.9% |
| Food and Beverage | $1,143 | 43 | 23.0% |
| Education | $103.06 | 2 | 2.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$4,961
47 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $3,715 | 7 | $0 (2021) |
| Novo Nordisk Inc | $328.41 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $283.79 | 10 | $0 (2018) |
| PFIZER INC. | $175.62 | 9 | $0 (2018) |
| Janssen Biotech, Inc. | $166.53 | 12 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $100.68 | 2 | $0 (2019) |
| Edwards Lifesciences Corporation | $83.47 | 1 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $60.78 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $16.70 | 1 | $0 (2017) |
| AbbVie, Inc. | $15.10 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $177.60 | 2 | Novo Nordisk Inc ($94.13) |
| 2021 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2020 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2019 | $211.41 | 4 | Novo Nordisk Inc ($105.66) |
| 2018 | $379.87 | 14 | PFIZER INC. ($134.52) |
| 2017 | $4,193 | 30 | Innovative Medical Technologies, LLC ($3,715) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $94.13 | General |
| 01/11/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $83.47 | General |
| 2021 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 2020 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 12/12/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $105.66 | General |
| 11/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $87.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/04/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Oncology | ||||||
| 2019 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 12/04/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $90.23 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 11/19/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Urology | ||||||
| 11/08/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $79.48 | General |
| Category: Diabetes | ||||||
| 10/23/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Urology | ||||||
| 10/15/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Urology | ||||||
| 07/09/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 03/05/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Urology | ||||||
| 2018 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 11/13/2017 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 10/26/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $118.56 | General |
About Dr. David Patrick, MD
Dr. David Patrick, MD is a Urology healthcare provider based in Beaver, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205873502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Patrick, MD has received a total of $4,961 in payments from pharmaceutical and medical device companies, with $177.60 received in 2024. These payments were reported across 52 transactions from 11 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($3,715).
Ad
Practice Information
- Specialty Urology
- Location Beaver, PA
- Active Since 06/02/2006
- Last Updated 01/09/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205873502
Products in Payments
- XTANDI (Drug) $175.62
- ZYTIGA (Drug) $161.46
- Tresiba (Drug) $128.62
- INVOKANA (Drug) $87.61
- Myrbetriq (Drug) $75.24
- Noctiva (Drug) $60.78
- Erleada (Drug) $18.14
- ZERBAXA (Drug) $16.70
- OFIRMEV (Drug) $14.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.